https://www.selleckchem.com/products/azd-1208.html
9% vs. 20.8%, P less then 0.05) and deficiency anemia (15.5% vs. 8.5%, P less then 0.05). At 90 days, MD patients were more likely to be readmitted (17.4% vs. 13.2%, P less then 0.05) and have a higher total cost ($94,672 vs. $85,190, P less then 0.05). After propensity-score match, the overall complication rate remained higher in the MD group (44.6% vs. 37.6%, P less then 0.05). 90-day readmissions and costs also remained significantly higher in the MD cohort. Multivariate modeling revealed MD was an independent predictor of